[Rio]

It ain’t cheap:

Merck said Keytruda (pembrolizumab) would cost $12,500 per patient per month, or $150,000 per year.

http://www.fiercepharma.com/pharma/updated-merck-s-melanoma-game-changer-keytruda-likely-to-bolster-drug-pricing-debate

[NorthMountain]

R&D ain’t cheap.

[ncfool]

I guess its your on Obamacare then you don’t get it and die. Think about the savings for the Federal Gov. But if your on Medicaid its probably approved as your a democrat.